Anticoccidial Drugs Market Overview:
Anticoccidial Drugs Market Forecast Report (2018-2023):
Global Anticoccidial Drugs Market is estimated to reach USD 1511.46 million by 2023 at a CAGR of 3.61%. The livestock industry has seen steady growth over the past two decades and the antibiotic market has been growing along with it.
Anticoccidial Drugs Market Growth:
The ban on consumption of antibiotics as a source of animal feed and the upsurge in incidences of antibiotic microbes has seen a reduced growth in the antibiotic market, nevertheless the rising incidence of coccidiosis over the preceding 50 years and its control on the overall cost to benefit ratio for the meat industry has furthered the anticoccidials drug market.
Growing demand for meat proteins are increasing usage of anticoccidial drugs and are the driving force for global anticoccidial drugs market. Besides, less stringent regulations and increased expenditure on companion animals are also assistant in growth of global anticoccidial drugs market. Further, the trend of owning companion animals is causative to the growing usage of anticoccidials in developing regions.
Anticoccidial Drugs Market Segmentation:
The global anticoccidial drugs market is classified based on various types of animals and by type of drugs. The animal segment is further sub-categorised into poultry, swine, fish, cattle and companion animals. The companion animal further includes dogs and cats. The drug segment includes antibiotic anticoccidials, Ionophore anticoccidials and chemical derivative anticoccidials. Furthermore, based on geography the market is segmented into various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
North America dominates the global anticoccidial drugs market owing to preventive usage of anticoccidials in animal feed. Its countries combined contribute around 24% of the worldwide market for anticoccidial drugs. The U.S. holds the largest market share for anticoccidial drugs followed by Mexico and Canada in North America. Germany, France, Spain and U.K holds major share of the European anticoccidial drugs market
The industry is and will remain to face diverse challenges related to microbial resistance build-up and government regulations in US and Europe, consequently the major players will be focusing on the not as much of regulated markets in the South America and Asia Pacific regions. These being the regions estimated to grow the most during the forecasted period.
Anticoccidial Drugs Market Key Players:
Some of the few key players operating in the market are Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Virbac, Ceva Santé Animale, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare and Smartvet Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Drug Type
5.1.1 Antibiotic anticoccidials
5.1.2 Ionophore anticoccidials
5.1.3 Chemical derivative anticoccidials
5.2 By Animal Type
5.2.1 Poultry
5.2.2 Swine
5.2.3 Fish
5.2.4 Cattle
5.2.5 Companion Animal
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Bayer Health care
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Zoetis
8.3 Elanco
8.4 Merck Animal Healthcare
8.5 Virbac
8.6 Ceva Santé Animale
8.7 Boehringer Ingelheim Animal Health
8.8 Novartis Animal Healthcare
8.9 Smartvet Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a.List of Tables
b.List of Figures
